Area of research
Immunology · Oncology
Research interest
Research interests include interferon and immune responses, Cytokine Signaling Pathways and Interactions, Protein Degradation and Inhibitors, and Cancer-related molecular mechanisms research.
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia
The Epigenetic Hallmarks of Cancer
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivation
HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults
Targeting the epigenetic regulation of antitumour immunity
Non-genetic mechanisms of therapeutic resistance in cancer
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia
5-Formylcytosine organizes nucleosomes and forms Schiff base interactions with histones in mouse embryonic stem cells
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Cancer Epigenetics: From Mechanism to Therapy